Journal of Gastrointestinal Surgery

, Volume 22, Issue 4, pp 615–623 | Cite as

Comparison of Hepatectomy for Patients with Metabolic Syndrome-Related HCC and HBV-Related HCC

  • Yunhong Tian
  • Huan Lyu
  • Yunhong He
  • Yong Xia
  • Jun Li
  • Feng Shen
Original Article



Metabolic syndrome (MetS) is a group of clinicopathological manifestations. The outcome of liver surgery in metabolic syndrome-related hepatocellular carcinoma (MetS-HCC) still needs to be evaluated. We aim to clarify the outcomes following liver resection in patients with MetS-HCC compared those with hepatitis B virus-related HCC (HBV-HCC).


All the consecutive patients undergoing hepatectomy for HCC between January 2009 and December 2012 were retrospectively considered. Patients were divided into three groups: MetS-HCC, MetS-HBV-HCC, and HBV-HCC. Data on clinical characteristics, postoperative complications, and long-term outcome were collected and analyzed.


A total of 1352 patients were included in this study. In MetS-HCC group, the severe morbidity rate was 33.33%, which was higher than that of HBV-HCC group (15.68%). In subgroup analysis, patients with MetS-HCC in American Joint Committee on Cancer (AJCC) stage I had superior DFS and OS when compared with those of the other two groups.


We should pay more attention to patients with MetS-HCC perioperatively due to the high rate of surgical complications. Nevertheless, curative treatment should be provided to patients with MetS.


Hepatectomy Metabolic syndrome Hepatitis virus B Hepatocellular carcinoma Surgery 


Author Contribution

Feng Shen and Yunhong Tian designed the research; Feng Shen, Jun Li, and Yong Xia performed the surgery and collected the data; Yunhong Tian, Jun Li, and Huan Lyu contributed to the discussion part. Huan Lyu and Yunhong He analyzed the data; Yunhong Tian wrote the paper.

All authors are in agreement with the contents of the manuscript and confirm that the paper is not being published or under consideration elsewhere.


This work was supported by the foundation of Sichuan Medical Association [S16045] and Health and Family Planning Commission of Sichuan Province [16PJ206].


  1. 1.
    Starley BQ, Calcagno CJ, Harrison SA. Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology. 2010;51(5):1820–32. Scholar
  2. 2.
    Welzel TM, Graubard BI, Zeuzem S, El-Serag HB, Davila JA, McGlynn KA. Metabolic syndrome increases the risk of primary liver cancer in the United States: a study in the SEER-Medicare database. Hepatology. 2011;54(2):463–71. Scholar
  3. 3.
    Jinjuvadia R, Patel S, Liangpunsakul S. The association between metabolic syndrome and hepatocellular carcinoma: systemic review and meta-analysis. Journal of clinical gastroenterology. 2014;48(2):172–7. Scholar
  4. 4.
    Cauchy F, Zalinski S, Dokmak S, Fuks D, Farges O, Castera L, Paradis V, Belghiti J. Surgical treatment of hepatocellular carcinoma associated with the metabolic syndrome. The British journal of surgery. 2013;100(1):113–21. Scholar
  5. 5.
    Vigano L, Conci S, Cescon M, Fava C, Capelli P, D'Errico A, Torzilli G, Di Tommaso L, Giuliante F, Vecchio FM, Salizzoni M, David E, Pinna AD, Guglielmi A, Capussotti L. Liver resection for hepatocellular carcinoma in patients with metabolic syndrome: A multicenter matched analysis with HCV-related HCC. Journal of hepatology. 2015;63(1):93–101. Scholar
  6. 6.
    Wong GL, Chan HL, Yu Z, Chan AW, Choi PC, Chim AM, Chan HY, Tse CH, Wong VW. Coincidental metabolic syndrome increases the risk of liver fibrosis progression in patients with chronic hepatitis B—a prospective cohort study with paired transient elastography examinations. Alimentary pharmacology & therapeutics. 2014;39(8):883–93. Scholar
  7. 7.
    Wong GL, Wong VW, Choi PC, Chan AW, Chim AM, Yiu KK, Chan HY, Chan FK, Sung JJ, Chan HL. Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B. Gut. 2009;58(1):111–7. Scholar
  8. 8.
    Huang G, Lai EC, Lau WY, Zhou WP, Shen F, Pan ZY, Fu SY, Wu MC. Posthepatectomy HBV reactivation in hepatitis B-related hepatocellular carcinoma influences postoperative survival in patients with preoperative low HBV-DNA levels. Annals of surgery. 2013;257(3):490–505. Scholar
  9. 9.
    Huang G, Lau WY, Zhou WP, Shen F, Pan ZY, Yuan SX, Wu MC. Prediction of Hepatocellular Carcinoma Recurrence in Patients With Low Hepatitis B Virus DNA Levels and High Preoperative Hepatitis B Surface Antigen Levels. JAMA surgery. 2014;149(6):519–27. Scholar
  10. 10.
    Alberti KG, Zimmet P, Shaw J, Group IDFETFC. The metabolic syndrome—a new worldwide definition. Lancet. 2005;366(9491):1059–62.CrossRefPubMedGoogle Scholar
  11. 11.
    Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. The British journal of surgery. 1973;60(8):646–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Malinchoc M, Kamath PS, Gordon FD, Peine CJ, Rank J, ter Borg PC. A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology. 2000;31(4):864–71. CrossRefPubMedGoogle Scholar
  13. 13.
    Editorial Board of the Chinese Journal of H. [A guideline for the use of nucleoside/tide analogues in treating chronic hepatitis B]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese Journal of Hepatology. 2008;16(5):335–40.Google Scholar
  14. 14.
    Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Annals of surgery. 2004;240(2):205–13.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Rahbari NN, Garden OJ, Padbury R, Brooke-Smith M, Crawford M, Adam R, Koch M, Makuuchi M, Dematteo RP, Christophi C, Banting S, Usatoff V, Nagino M, Maddern G, Hugh TJ, Vauthey JN, Greig P, Rees M, Yokoyama Y, Fan ST, Nimura Y, Figueras J, Capussotti L, Büchler MW, Weitz J. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149(5):713–24. Scholar
  16. 16.
    SB. E. American Joint Committee on Cancer; ACS. AJCC Cancer Staging Manual. 7th ed: New York: Springer; 2009.Google Scholar
  17. 17.
    El-Serag HB. Hepatocellular carcinoma. The New England journal of medicine. 2011;365(12):1118–27. Scholar
  18. 18.
    Siegel AB, Zhu AX. Metabolic syndrome and hepatocellular carcinoma: two growing epidemics with a potential link. Cancer. 2009;115(24):5651–61. Scholar
  19. 19.
    Wakai T, Shirai Y, Sakata J, Korita PV, Ajioka Y, Hatakeyama K. Surgical outcomes for hepatocellular carcinoma in nonalcoholic fatty liver disease. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract. 2011;15(8):1450–8. Scholar
  20. 20.
    Paradis V, Zalinski S, Chelbi E, Guedj N, Degos F, Vilgrain V, Bedossa P, Belghiti J. Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: a pathological analysis. Hepatology. 2009;49(3):851–9. Scholar
  21. 21.
    Bucci L, Garuti F, Lenzi B, Pecorelli A, Farinati F, Giannini EG, Granito A, Ciccarese F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Sacco R, Cammà C, Virdone R, Marra F, Felder M, Morisco F, Benvegnù L, Gasbarrini A, Svegliati-Baroni G, Foschi FG, Missale G, Masotto A, Nardone G, Colecchia A, Bernardi M, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group. The evolutionary scenario of hepatocellular carcinoma in Italy: an update. Liver international: official journal of the International Association for the Study of the Liver. 2017;37(2):259–70. Scholar
  22. 22.
    Mathur AK, Ghaferi AA, Osborne NH, Pawlik TM, Campbell DA, Englesbe MJ, Welling TH. Body mass index and adverse perioperative outcomes following hepatic resection. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract. 2010;14(8):1285–91. Scholar
  23. 23.
    Cucchetti A, Cescon M, Ercolani G, Di Gioia P, Peri E, Pinna AD. Safety of hepatic resection in overweight and obese patients with cirrhosis. The British journal of surgery. 2011;98(8):1147–54. Scholar
  24. 24.
    Zarzavadjian Le Bian A, Costi R, Constantinides V, Smadja C. Metabolic disorders, non-alcoholic fatty liver disease and major liver resection: an underestimated perioperative risk. Journal of gastrointestinal surgery: official journal of the Society for Surgery of the Alimentary Tract. 2012;16(12):2247–55. Scholar
  25. 25.
    Bhayani NH, Hyder O, Frederick W, Schulick RD, Wolgang CL, Hirose K, et al. Effect of metabolic syndrome on perioperative outcomes after liver surgery: A National Surgical Quality Improvement Program (NSQIP) analysis. Surgery. 2012;152(2):218–26. Scholar
  26. 26.
    Reddy SK, Marsh JW, Varley PR, Mock BK, Chopra KB, Geller DA, Tsung A.. Underlying steatohepatitis, but not simple hepatic steatosis, increases morbidity after liver resection: a case-control study. Hepatology. 2012;56(6):2221–30. Scholar
  27. 27.
    de Meijer VE, Kalish BT, Puder M, Ijzermans JN. Systematic review and meta-analysis of steatosis as a risk factor in major hepatic resection. The British journal of surgery. 2010;97(9):1331–9. Scholar
  28. 28.
    Vetelainen R, van Vliet A, Gouma DJ, van Gulik TM. Steatosis as a risk factor in liver surgery. Annals of surgery. 2007;245(1):20–30. Scholar
  29. 29.
    Kamiyama T, Nakanishi K, Yokoo H, Kamachi H, Tahara M, Yamashita K, Taniguchi M, Shimamura T, Matsushita M, Todo S. Perioperative management of hepatic resection toward zero mortality and morbidity: analysis of 793 consecutive cases in a single institution. Journal of the American College of Surgeons. 2010;211(4):443–9. Scholar
  30. 30.
    Utsunomiya T, Okamoto M, Kameyama T, Matsuyama A, Yamamoto M, Fujiwara M, Mori M, Aimitsu S, Ishida T. Impact of obesity on the surgical outcome following repeat hepatic resection in Japanese patients with recurrent hepatocellular carcinoma. World journal of gastroenterology. 2008;14(10):1553–8.CrossRefPubMedPubMedCentralGoogle Scholar
  31. 31.
    Kawamura Y, Ikeda K, Arase Y, Yatsuji H, Sezaki H, Hosaka T, Akuta N, Kobayashi M, Saitoh S, Suzuki F, Suzuki Y, Kumada H. Diabetes mellitus worsens the recurrence rate after potentially curative therapy in patients with hepatocellular carcinoma associated with nonviral hepatitis. Journal of gastroenterology and hepatology. 2008;23(11):1739–46. Scholar
  32. 32.
    Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. The New England Journal of Medicine. 2003;348(17):1625–38. Scholar
  33. 33.
    Kant P, Hull MA. Excess body weight and obesity—the link with gastrointestinal and hepatobiliary cancer. Nature reviews Gastroenterology & hepatology. 2011;8(4):224–38. Scholar

Copyright information

© The Society for Surgery of the Alimentary Tract 2017

Authors and Affiliations

  • Yunhong Tian
    • 1
    • 2
    • 3
  • Huan Lyu
    • 3
  • Yunhong He
    • 3
  • Yong Xia
    • 1
  • Jun Li
    • 1
  • Feng Shen
    • 1
  1. 1.Department of Hepatic Surgery, Eastern Hepatobiliary Surgery HospitalThe Second Military Medical UniversityShanghaiChina
  2. 2.Graduate School of Soochow UniversitySuzhouChina
  3. 3.Department of General SurgeryNanchong Central HospitalNanchongChina

Personalised recommendations